{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,3,19]],"date-time":"2024-03-19T00:25:09Z","timestamp":1710807909261},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,3,18]]},"DOI":"10.7759\/cureus.56376","type":"journal-article","created":{"date-parts":[[2024,3,18]],"date-time":"2024-03-18T14:37:41Z","timestamp":1710772661000},"source":"Crossref","is-referenced-by-count":0,"title":["Two Cases Showing That Cilostazol Administration Leads to an Increase in Cerebral Blood Flow and Has a Positive Effect on Rehabilitation"],"prefix":"10.7759","author":[{"given":"Shuji","family":"Matsumoto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rintaro","family":"Ohama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Hoei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryuji","family":"Tojo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshihiro","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000207387","article-title":"Global burden, risk factor analysis, and prediction study of ischemic stroke, 1990-2030","volume":"101","author":"Fan J","year":"2023","unstructured":"Fan J, Li X, Yu X, et al.. Global burden, risk factor analysis, and prediction study of ischemic stroke, 1990-2030. Neurology. 2023, 101:137-50. 10.1212\/WNL.0000000000207387","journal-title":"Neurology"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1161\/STR.0000000000000024","article-title":"Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association\/American Stroke Association","volume":"45","author":"Kernan WN","year":"2014","unstructured":"Kernan WN, Ovbiagele B, Black HR, et al.. Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association\/American Stroke Association. Stroke. 2014, 45:2160-236. 10.1161\/STR.0000000000000024","journal-title":"Stroke"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/s0049-3848(99)00109-7","article-title":"Effect of cilostazol, a phosphodiesterase \u2162 inhibitor, on experimental thrombosis in the porcine carotid artery","volume":"15","author":"Kohda N","year":"1999","unstructured":"Kohda N, Tani T, Nakayama S, et al.. Effect of cilostazol, a phosphodiesterase \u2162 inhibitor, on experimental thrombosis in the porcine carotid artery. Thromb Res. 1999, 15:261-8. 10.1016\/s0049-3848(99)00109-7","journal-title":"Thromb Res"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1159\/000138400","article-title":"Effects of cilostazol, a selective cAMP phosphodiesterase inhibitor on the contraction of vascular smooth muscle","volume":"36","author":"Tanaka T","year":"1988","unstructured":"Tanaka T, Ishikawa T, Hagiwara M, Onoda K, Itoh H, Hidaka H. Effects of cilostazol, a selective cAMP phosphodiesterase inhibitor on the contraction of vascular smooth muscle. Pharmacology. 1988, 36:313-20. 10.1159\/000138400","journal-title":"Pharmacology"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.2170\/jjphysiol.52.471","article-title":"Effects of cilostazol, a selective cyclic AMP phosphodiesterase inhibitor on isolated rabbit spinal arterioles","volume":"52","author":"Yashiro Y","year":"2002","unstructured":"Yashiro Y, Ohhashi T. Effects of cilostazol, a selective cyclic AMP phosphodiesterase inhibitor on isolated rabbit spinal arterioles. Jpn J Physiol. 2002, 52:471-7. 10.2170\/jjphysiol.52.471","journal-title":"Jpn J Physiol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.300.2.709","article-title":"Inhibition of lipopolysaccharide-induced apoptosis by cilostazol in human umbilical vein endothelial cells","volume":"300","author":"Kim KY","year":"2002","unstructured":"Kim KY, Shin HK, Choi JM, Hong KW. Inhibition of lipopolysaccharide-induced apoptosis by cilostazol in human umbilical vein endothelial cells. J Pharmacol Exp Ther. 2002, 300:709-15. 10.1124\/jpet.300.2.709","journal-title":"J Pharmacol Exp Ther"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1097\/00005344-199212000-00009","article-title":"Effect of cilostazol, a cyclic AMP phosphodiesterase inhibitor, on the proliferation of rat aortic smooth muscle cells in culture","volume":"20","author":"Takahashi S","year":"1992","unstructured":"Takahashi S, Oida K, Fujiwara R, et al.. Effect of cilostazol, a cyclic AMP phosphodiesterase inhibitor, on the proliferation of rat aortic smooth muscle cells in culture. J Cardiovasc Pharmacol. 1992, 20:900-6. 10.1097\/00005344-199212000-00009","journal-title":"J Cardiovasc Pharmacol"},{"key":"ref8","article-title":"Effect of cilostazol on cerebral blood flows in chronic stage of cerebral circulation","volume":"49","author":"Oishi M","year":"2000","unstructured":"Oishi M, Mochizuki Y, Shikata E, et al.. Effect of cilostazol on cerebral blood flows in chronic stage of cerebral circulation. Keio J Med. 2000, 49:145-7.","journal-title":"Keio J Med"},{"key":"ref9","article-title":"The wash-in\/wash-out protocol in stable xenon CT cerebral blood flow studies","volume":"13","author":"Kashiwagi S","year":"1992","unstructured":"Kashiwagi S, Yamashita T, Nakano S, et al.. The wash-in\/wash-out protocol in stable xenon CT cerebral blood flow studies. Am J Neuroradiol. 1992, 13:49-53.","journal-title":"Am J Neuroradiol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1053\/jscd.2000.7216","article-title":"Cilostazol stroke prevention study: a placebo-controlled double-blind trial for secondary prevention of cerebral infarction","volume":"9","author":"Gotoh F","year":"2000","unstructured":"Gotoh F, Tohgi H, Hirai S, et al.. Cilostazol stroke prevention study: a placebo-controlled double-blind trial for secondary prevention of cerebral infarction. J Stroke Cerebrovasc Dis. 2000, 9:147-57. 10.1053\/jscd.2000.7216","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1161\/01.STR.0000157667.06542.b7","article-title":"Cilostazol prevents the progression of the symptomatic intracranial arterial stenosis: the multicenter double-blind placebo-controlled trial of cilostazol in symptomatic intracranial arterial stenosis","volume":"36","author":"Kwon SU","year":"2005","unstructured":"Kwon SU, Cho YJ, Koo JS, et al.. Cilostazol prevents the progression of the symptomatic intracranial arterial stenosis: the multicenter double-blind placebo-controlled trial of cilostazol in symptomatic intracranial arterial stenosis. Stroke. 2005, 36:782-6. 10.1161\/01.STR.0000157667.06542.b7","journal-title":"Stroke"},{"key":"ref12","article-title":"CAST: randomised placebo-controlled trial of early aspirin use in 20,000 patients with acute ischaemic stroke","volume":"349","author":"CAST Collaboration Group","year":"1997","unstructured":"CAST Collaboration Group. CAST: randomised placebo-controlled trial of early aspirin use in 20,000 patients with acute ischaemic stroke. Lancet. 1997, 349:1641-9.","journal-title":"Lancet"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1001\/jama.280.22.1930","article-title":"Aspirin and risk of hemorrhagic stroke: a meta-analysis of randomized controlled trials","volume":"280","author":"He J","year":"1998","unstructured":"He J, Whelton PK, Vu B, Klag MJ. Aspirin and risk of hemorrhagic stroke: a meta-analysis of randomized controlled trials. JAMA. 1998, 280:1930-5. 10.1001\/jama.280.22.1930","journal-title":"JAMA"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jstrokecerebrovasdis.2014.12.002","article-title":"Efficacy and safety of cilostazol therapy in ischemic stroke: a meta-analysis","volume":"24","author":"Tan L","year":"2015","unstructured":"Tan L, Margaret B, Zhang JH, et al.. Efficacy and safety of cilostazol therapy in ischemic stroke: a meta-analysis. J Stroke Cerebrovasc Dis. 2015, 24:930-8. 10.1016\/j.jstrokecerebrovasdis.2014.12.002","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/s0014-2999(99)00171-5","article-title":"Delayed administration of ethyl eicosapentate improves local cerebral blood flow and metabolism without affecting infarct volumes in the rat focal ischemic model","volume":"372","author":"Katsumata T","year":"1999","unstructured":"Katsumata T, Katayama Y, Obo R, et al.. Delayed administration of ethyl eicosapentate improves local cerebral blood flow and metabolism without affecting infarct volumes in the rat focal ischemic model. Eur J Pharmacol. 1999, 372:167-74. 10.1016\/s0014-2999(99)00171-5","journal-title":"Eur J Pharmacol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1161\/01.str.0000019511.81583.a8","article-title":"Cerebrovascular reactivity to acetazolamide and outcome in patients with symptomatic internal carotid or middle cerebral artery occlusion: a xenon-133 single-photon emission computed tomography study","volume":"33","author":"Ogasawara K","year":"2002","unstructured":"Ogasawara K, Ogawa A, Yoshimoto T. Cerebrovascular reactivity to acetazolamide and outcome in patients with symptomatic internal carotid or middle cerebral artery occlusion: a xenon-133 single-photon emission computed tomography study. Stroke. 2002, 33:1857-62. 10.1161\/01.str.0000019511.81583.a8","journal-title":"Stroke"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.3171\/jns.1977.46.4.0484","article-title":"Effects of cyclic AMP and dibutyryl cyclic AMP on cerebral hemodynamics and metabolism in the baboon","volume":"46","author":"Tagashira Y","year":"1977","unstructured":"Tagashira Y, Matsuda M, Welch KM, Chabi E, Meyer JS. Effects of cyclic AMP and dibutyryl cyclic AMP on cerebral hemodynamics and metabolism in the baboon. J Neurosurg. 1977, 46:484-93. 10.3171\/jns.1977.46.4.0484","journal-title":"J Neurosurg"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1161\/01.STR.0000221783.08037.a9","article-title":"Cilostazol protects against brain white matter damage and cognitive impairment in a rat model of chronic cerebral hypoperfusion","volume":"37","author":"Watanabe T","year":"2006","unstructured":"Watanabe T, Zhang N, Liu M, Tanaka R, Mizuno Y, Urabe T. Cilostazol protects against brain white matter damage and cognitive impairment in a rat model of chronic cerebral hypoperfusion. Stroke. 2006, 37:1539-45. 10.1161\/01.STR.0000221783.08037.a9","journal-title":"Stroke"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.300.3.787","article-title":"Neuroprotective effect of cilostazol against focal cerebral ischemia via antiapoptotic action in rats","volume":"300","author":"Choi JM","year":"2002","unstructured":"Choi JM, Shin HK, Kim KY, Lee JH, Hong KW. Neuroprotective effect of cilostazol against focal cerebral ischemia via antiapoptotic action in rats. J Pharmacol Exp Ther. 2002, 300:787-93. 10.1124\/jpet.300.3.787","journal-title":"J Pharmacol Exp Ther"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.103.061853","article-title":"Cilostazol prevents focal cerebral ischemic injury by enhancing casein kinase 2 phosphorylation and suppression of phosphatase and tensin homolog deleted from chromosome 10 phosphorylation in rats","volume":"308","author":"Lee JH","year":"2004","unstructured":"Lee JH, Kim KY, Lee YK, et al.. Cilostazol prevents focal cerebral ischemic injury by enhancing casein kinase 2 phosphorylation and suppression of phosphatase and tensin homolog deleted from chromosome 10 phosphorylation in rats. J Pharmacol Exp Ther. 2004, 308:896-903. 10.1124\/jpet.103.061853","journal-title":"J Pharmacol Exp Ther"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/237671-two-cases-showing-that-cilostazol-administration-leads-to-an-increase-in-cerebral-blood-flow-and-has-a-positive-effect-on-rehabilitation","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,18]],"date-time":"2024-03-18T14:37:47Z","timestamp":1710772667000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/237671-two-cases-showing-that-cilostazol-administration-leads-to-an-increase-in-cerebral-blood-flow-and-has-a-positive-effect-on-rehabilitation"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,18]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.56376","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3,18]]}}}